Trump announces steep tariffs on imported generic drugs, starting 100% in 2028 and rising to 200% in 2029

President Donald Trump disclosed a plan to levy heavy tariffs on generic medicines that are imported into the United States. The tariff would be set at 100 percent beginning in August 2028 and would double to 200 percent in August 2029.

The administration says the measure is intended to encourage pharmaceutical manufacturing to return to U.S. facilities and reduce reliance on foreign sources.

Industry observers note that the proposal could disrupt supply chains for low-cost generics, particularly affecting manufacturers in India that export large volumes to the American market.